Evidence-based tumor response assessment with imaging in bone metastases from breast cancer Conclusion: The optical biopsy system has the ability to instantly determine the histological status of ...

As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

MIAMI--(BUSINESS WIRE)--DermaSensor Inc. – Skin cancer is a global health concern, with increasing incidence rates worldwide. Artificial Intelligence (AI) is expanding its presence within dermatology ...

MIAMI, Aug. 14, 2020 /PRNewswire/ -- DermaSensor Inc., a health technology company designing tools to better equip primary care providers (PCPs) to detect skin cancer, is unveiling its decade of ...

Please provide your email address to receive an email when new articles are posted on . The device achieved an overall sensitivity of 97.04%. The device had an overall specificity of 26.22%, a ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

Dermasensor Inc.’s elastic scattering spectroscopy device appears to have solved one of the more challenging issues in dermatology—early detection of skin cancers in individuals with darker skin tones ...

The early diagnosis of most types of skin cancer is directly related to improved survival rates. The DermaSensor device is a revolutionary, non-invasive and spectroscopy-based tool that can assist ...